EP0486584A4 - Dopaminergic neurotrophic factor for treatment of parkinson's disease - Google Patents

Dopaminergic neurotrophic factor for treatment of parkinson's disease

Info

Publication number: EP0486584A4
Authority: EP; European Patent Office
Prior art keywords: parkinson; disease; treatment; neurotrophic factor; dopaminergic neurotrophic
Prior art date: 1989-08-11
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP19900912528

Other versions

EP0486584A1 (en

Inventor

Joe E. Springer

Timothy J. Collier

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Hahnemann University

Original Assignee

Hahnemann University

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-08-11

Filing date

1990-08-09

Publication date

1993-02-03

1990-08-09 Application filed by Hahnemann University filed Critical Hahnemann University

1992-05-27 Publication of EP0486584A1 publication Critical patent/EP0486584A1/en

1993-02-03 Publication of EP0486584A4 publication Critical patent/EP0486584A4/en

Status Withdrawn legal-status Critical Current

Links

108010025020 Nerve Growth Factor Proteins 0.000 title 1
102000007072 Nerve Growth Factors Human genes 0.000 title 1
208000018737 Parkinson disease Diseases 0.000 title 1
230000003291 dopaminomimetic effect Effects 0.000 title 1
239000003900 neurotrophic factor Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Cell Biology (AREA)
Veterinary Medicine (AREA)
Zoology (AREA)
Developmental Biology & Embryology (AREA)
Pharmacology & Pharmacy (AREA)
Neurosurgery (AREA)
Animal Behavior & Ethology (AREA)
Neurology (AREA)
Public Health (AREA)
Biotechnology (AREA)
Toxicology (AREA)
Chemical Kinetics & Catalysis (AREA)
Ophthalmology & Optometry (AREA)
General Chemical & Material Sciences (AREA)
Immunology (AREA)
Virology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

EP19900912528 1989-08-11 1990-08-09 Dopaminergic neurotrophic factor for treatment of parkinson's disease Withdrawn EP0486584A4 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US39273389A	1989-08-11	1989-08-11
US392733		1989-08-11

Publications (2)

Publication Number	Publication Date
EP0486584A1 EP0486584A1 (en)	1992-05-27
EP0486584A4 true EP0486584A4 (en)	1993-02-03

Family

ID=23551803

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP19900912528 Withdrawn EP0486584A4 (en)	1989-08-11	1990-08-09	Dopaminergic neurotrophic factor for treatment of parkinson's disease

Country Status (4)

Country	Link
EP (1)	EP0486584A4 (en)
JP (1)	JPH04507251A (en)
CA (1)	CA2064787A1 (en)
WO (1)	WO1991001739A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1993006116A1 (en) *	1991-09-20	1993-04-01	Syntex-Synergen Neuroscience Joint Venture	Glial derived neurotrophic factor
US5245896A (en) *	1992-08-19	1993-09-21	Kennametal Inc.	Quick-change tool holder with center height adjustment mechanism
CZ365097A3 (en) *	1995-05-24	1998-02-18	Cellfactors Plc.	Agents for differentiation of cells
US6277820B1 (en)	1998-04-09	2001-08-21	Genentech, Inc.	Method of dopaminergic and serotonergic neuron formation from neuroprogenitor cells
WO2000033813A1 (en) *	1998-12-09	2000-06-15	Chiron Corporation	Administration of neurotrophic agents to the central nervous system

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4699875A (en) *	1982-11-24	1987-10-13	Baylor College Of Medicine	Diagnosis of amyotrophic lateral sclerosis by neurotrophic factors
US5017375A (en) *	1982-11-24	1991-05-21	Baylor College Of Medicine	Method to prepare a neurotrophic composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4701407A (en) *	1982-11-24	1987-10-20	Baylor College Of Medicine	Diagnosis of Alzheimer disease

1990
- 1990-08-09 CA CA002064787A patent/CA2064787A1/en not_active Abandoned
- 1990-08-09 EP EP19900912528 patent/EP0486584A4/en not_active Withdrawn
- 1990-08-09 WO PCT/US1990/004470 patent/WO1991001739A1/en not_active Ceased
- 1990-08-09 JP JP2511890A patent/JPH04507251A/en active Pending

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4699875A (en) *	1982-11-24	1987-10-13	Baylor College Of Medicine	Diagnosis of amyotrophic lateral sclerosis by neurotrophic factors
US5017375A (en) *	1982-11-24	1991-05-21	Baylor College Of Medicine	Method to prepare a neurotrophic composition

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9101739A1 *

Also Published As

Publication number	Publication date
WO1991001739A1 (en)	1991-02-21
EP0486584A1 (en)	1992-05-27
JPH04507251A (en)	1992-12-17
CA2064787A1 (en)	1991-02-12

Similar Documents

Publication	Publication Date	Title
EP0541686A4 (en)	1993-12-29	Tachykinin agonists for treatment of alzheimer's disease
EP0331620A3 (en)	1990-05-23	Agent for the treatment of parkinson's disease
AP9000206A0 (en)	1990-10-31	Treatment of conditions & diseases
HUT68635A (en)	1995-07-28	Tissue moisturizing composition and process for production of this
AU6905391A (en)	1991-06-26	Methods and compositions for the treatment of hodgkin's disease
IL86423A0 (en)	1988-11-15	Pharmaceutical compositions for the treatment of alzheimer's disease
IL95946A0 (en)	1991-07-18	Preparation of tetrabromo-4,4'-alkylidenediphenols
AU4759390A (en)	1990-06-26	Method of medical treatment of alzheimer's disease
US5011841B1 (en)	1994-09-06	Treatment of depression
NZ235610A (en)	1993-09-27	Treating bone diseases with bafilomycin-type compounds
EP0389110A3 (en)	1990-12-19	Process for the preparation of 2'-deoxy-5-trifluoromethyl-beta-uridine
AU1807592A (en)	1992-12-10	New combination preparation for treatment of parkinson's disease
ZA914435B (en)	1992-03-25	Treatment of disease
EP0457671A3 (en)	1992-04-08	Dipyridamide for the treatment of diseases of the central or peripheral nervous system
IL92465A0 (en)	1990-08-31	Process for the preparation of 4,4'-dibromodiphenylether
ZA909314B (en)	1991-09-25	Treatment of hsv
GB2210040B (en)	1991-02-27	The new process for the preparation of 3-(4'-bromobiphenyl-4-yl) tetralin-1-one
EP0425974A3 (en)	1991-07-03	Process for the preparation and purification of 2-hydroxy-4-(2'-hydroxy-ethoxy)-phenylarylketones
HU907632D0 (en)	1991-06-28	Process for producing tetra-o-acetyl-d-o-glycosides of 4'-desmethyl-4'-alkoxy-carbonyl-epidophyllotoxines
PH22450A (en)	1988-09-12	Agent for treating parkinson's disease or parkinsonism
ZA915462B (en)	1992-04-29	Composition for the treatment of alzheimer's disease and process for preparing the same
AU1012588A (en)	1989-07-13	Method of treatment of central nervous system diseases such as alzheimer's disease and parkinson's disease and method of diagnosing alzheimer's disease
GB8925512D0 (en)	1989-12-28	Therapy for alzheimer's disease
GB9010190D0 (en)	1990-06-27	Composition for the treatment of protozoal disease and their use
GB8728036D0 (en)	1988-01-06	Therapy for alzheimer's disease

Legal Events

Date	Code	Title	Description
1992-04-10	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
1992-05-27	17P	Request for examination filed	Effective date: 19920229
1992-05-27	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB IT LI LU NL SE
1993-02-03	A4	Supplementary search report drawn up and despatched
1993-02-03	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB IT LI LU NL SE
1994-10-26	17Q	First examination report despatched	Effective date: 19940907
1996-03-15	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
1996-05-01	18D	Application deemed to be withdrawn	Effective date: 19951103